Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
Learn more about:
Related Clinical Trial
The Oklahoma Parent-Child Assistance Program
Multisensorial Analysis of Human Activity for Diagnosis and Early Detection of Functional Limitations
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
Fetal Alcohol Damage Prevention Study
Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
Healthy Moms Alcohol Intervention
Expansion to Interdisciplinary HIV Prevention in Women
In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
Prenatal Alcohol Biomarker Study in Uruguay
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)
Fetal Alcohol Syndrome: Socio-Cognitive Habilitation
Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
Fetal Alcohol Syndrome/ARND Research Consortion
Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)